[Current problems of the clinical use of cardiac glycosides].
D002301:Cardiac Glycosides / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use* / Q000633:toxicity; D002318:Cardiovascular Diseases / Q000139:chemically induced; D004071:Digitalis Glycosides / Q000627:therapeutic use / Q000633:toxicity; D004342:Drug Hypersensitivity; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D007275:Injections, Intravenous; D007421:Intestine, Small / Q000378:metabolism; D009422:Nervous System Diseases / Q000139:chemically induced; D008517:Phytotherapy; D010946:Plants, Medicinal / Q000627:therapeutic use / Q000633:toxicity; D011208:Powders; D013328:Strophanthins / Q000627:therapeutic use / Q000633:toxicity; D014786:Vision Disorders / Q000139:chemically induced
D002301:Cardiac Glycosides; D004071:Digitalis Glycosides; D011208:Powders; D013328:Strophanthins
Aktual'nye voprosy klinicheskogo primeneniia serdechnykh glikozidov.